Related Experiment Video
Updated: Jun 28, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Improving Statin Prescribing for People Living With HIV: A Quality Improvement Initiative
Veronica Njuguna1, John Hawkins1, Navya Pothamsetty2
1Graduate Medical Education, Kaiser Permanente Oakland Medical Center, Oakland, California, USA.
Improving statin prescribing for people living with HIV (PLWH) is crucial due to their increased cardiovascular risk. A quality improvement initiative significantly boosted statin prescriptions through education and feedback.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- People living with HIV (PLWH) face elevated risks of atherosclerotic cardiovascular disease.
- Current guidelines advocate for statin therapy in eligible PLWH (aged 40-75 with ≥5% 10-year ASCVD risk).
- Statin prescribing remains suboptimal in this patient group.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Coronary Artery Disease V: Interprofessional Care
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Coronary Artery Disease IV: Preventive Measures
